Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Absa Group Limited | AU61 | Nov 22, 2024 | 8.95 | -2.19 |
ABSOLICON SOLAR COLLEC. B | ZY0 | Nov 22, 2024 | 0.40 | +0.51 |
AC Immune SA | IMR | Nov 22, 2024 | 3.06 | +0.82 |
Acacia Research Corporation | AZG2 | Nov 22, 2024 | 4.24 | +2.91 |
AcadeMedia | V8T | Nov 22, 2024 | 5.31 | +1.92 |
Acadia Healthcare Company, Inc. | 7RA | Nov 22, 2024 | 36.00 | +0.56 |
ACADIA Pharmaceuticals Inc. | DR6 | Nov 22, 2024 | 15.34 | +0.26 |
Acadia Realty Trust | WX1 | Nov 22, 2024 | 24.20 | +1.68 |
Acadian Timber Corp | 779 | Nov 22, 2024 | 12.20 | +3.39 |
Acanthe Developpement SA | ADX | Nov 22, 2024 | 0.31 | 0.00 |
Acarix | 7AC | Nov 22, 2024 | 0.03 | -1.18 |
Acast AB | 0PN | Nov 22, 2024 | 1.27 | +1.19 |
Accelerate Diagnostics | 1A80 | Nov 22, 2024 | 1.59 | 0.00 |
ACCELLERON IND. ADR/1 | ZH20 | Nov 22, 2024 | 56.00 | +10.89 |
Accent Resources NL | A2R | Nov 22, 2024 | 0.02 | +63.64 |
Accentis S.A. | D1Z | Nov 22, 2024 | 0.02 | +2.27 |
Accentro Real Estate AG | A4Y | Nov 22, 2024 | 0.29 | +32.43 |
Accenture plc Class A Ordinary Shares (Ireland) | CSA | Nov 22, 2024 | 345.20 | -0.19 |
Accesso Technology Group Plc | LQG | Nov 22, 2024 | 6.15 | -1.60 |
Acciona SA | AJ3 | Nov 22, 2024 | 115.70 | +0.70 |
Acco Brands Corporation | A3B | Nov 22, 2024 | 5.35 | 0.00 |
Accolade, Inc. | 4NE1 | Nov 22, 2024 | 3.50 | +4.79 |
Acconeer | 2LU | Nov 22, 2024 | 0.42 | -0.24 |
Accor | ACR1 | Nov 22, 2024 | 8.50 | +1.19 |
Accor SA | ACR | Nov 22, 2024 | 42.93 | +0.28 |
Accsys Technologies | 1D8 | Nov 22, 2024 | 0.52 | +3.77 |
Accuray Incorporated | XEJ | Nov 22, 2024 | 1.78 | +4.09 |
Ace Hardware Indonesia TBK | 4AH1 | Nov 22, 2024 | 0.04 | -2.47 |
ACE LIBERTY+STONE LS -,25 | 8MW | Nov 22, 2024 | 0.54 | 0.00 |
ACEA SpA | DCA | Nov 22, 2024 | 17.37 | +0.17 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.